Assessment of ATP metabolism to adenosine by ecto-nucleotidases carried by tumor-derived small extracellular vesicles.
Derived
High pressure liquid chromatography
N6-etheno-ADP
N6-etheno-AMP
N6-etheno-ATP
N6-etheno-adenosine
Small extracellular
Tumor
Vesicles
Journal
Purinergic signalling
ISSN: 1573-9546
Titre abrégé: Purinergic Signal
Pays: Netherlands
ID NLM: 101250499
Informations de publication
Date de publication:
27 Jul 2024
27 Jul 2024
Historique:
received:
18
01
2024
accepted:
04
07
2024
medline:
28
7
2024
pubmed:
28
7
2024
entrez:
27
7
2024
Statut:
aheadofprint
Résumé
Immunosuppression is a hallmark of cancer progression. Tumor-derived small extracellular vesicles (sEV), also known as TEX, produce adenosine (ADO) and can mediate tumor-induced immunosuppression.Here, the ATP pathway of ADO production (ATP
Identifiants
pubmed: 39066830
doi: 10.1007/s11302-024-10038-7
pii: 10.1007/s11302-024-10038-7
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIH HHS
ID : R01-CA 256068
Pays : United States
Organisme : NIH HHS
ID : UO1-DE029759
Pays : United States
Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer Nature B.V.
Références
Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674. https://doi.org/10.1016/j.cell.2011.02.013
doi: 10.1016/j.cell.2011.02.013
pubmed: 21376230
Czystowska-Kuzmicz M, Whiteside TL (2021) The potential role of tumor-derived exosomes in diagnosis, prognosis, and response to therapy in cancer. Expert Opin Biol Ther 21:241–258. https://doi.org/10.1080/14712598.2020.1813276
doi: 10.1080/14712598.2020.1813276
pubmed: 32813990
Olejarz W, Dominiak A, Zolnierzak A, Kubiak-Tomaszewska G, Lorenc T (2020) Tumor-derived exosomes in immunosuppression and immunotherapy. J Immunol Res 2020:6272498. https://doi.org/10.1155/2020/6272498
doi: 10.1155/2020/6272498
pubmed: 32537468
pmcid: 7261328
Whiteside TL (2017) Exosomes in cancer: another mechanism of tumor-induced immune suppression. Adv Exp Med Biol 1036:81–89. https://doi.org/10.1007/978-3-319-67577-0_6
doi: 10.1007/978-3-319-67577-0_6
pubmed: 29275466
Abels ER, Breakefield XO (2016) Introduction to extracellular vesicles: biogenesis, RNA cargo selection, content, release, and uptake. Cell Mol Neurobiol 36:301–312. https://doi.org/10.1007/s10571-016-0366-z
doi: 10.1007/s10571-016-0366-z
pubmed: 27053351
pmcid: 5546313
Kalluri R, LeBleu VS (2020) The biology, function, and biomedical applications of exosomes. 367. https://doi.org/10.1126/science.aau6977
Hurwitz SN (2016) Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers. Oncotarget 7:86999–87015. https://doi.org/10.18632/oncotarget.13569
doi: 10.18632/oncotarget.13569
pubmed: 27894104
pmcid: 5341331
Maas SLN, Breakefield XO, Weaver AM (2017) Extracellular vesicles: unique intercellular delivery vehicles. Trends Cell Biol 27:172–188. https://doi.org/10.1016/j.tcb.2016.11.003
doi: 10.1016/j.tcb.2016.11.003
pubmed: 27979573
Atay S, Godwin AK (2014) Tumor-derived exosomes: a message delivery system for tumor progression. Commun Integr Biol 7:e28231. https://doi.org/10.4161/cib.28231
doi: 10.4161/cib.28231
pubmed: 24778765
pmcid: 3995727
Ludwig N, Yerneni SS, Razzo BM, Whiteside TL (2018) Exosomes from HNSCC promote angiogenesis through reprogramming of endothelial cells. Mol Cancer Res 16:1798–1808. https://doi.org/10.1158/1541-7786.MCR-18-0358
doi: 10.1158/1541-7786.MCR-18-0358
pubmed: 30042174
Crow J, Samuel G, Godwin AK (2019) Beyond tumor mutational burden: potential and limitations in using exosomes to predict response to immunotherapy. Expert Rev Mol Diagn 19:1079–1088. https://doi.org/10.1080/14737159.2020.1688144
doi: 10.1080/14737159.2020.1688144
pubmed: 31687863
Whiteside TL (2023) Evaluating tumor cell- and T cell-derived extracellular vesicles as potential biomarkers of cancer and immune cell competence. Expert Rev Mol Diagn 23:109–122. https://doi.org/10.1080/14737159.2023.2178902
doi: 10.1080/14737159.2023.2178902
pubmed: 36787282
pmcid: 9998373
Peinado H (2012) Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med 18:883–891. https://doi.org/10.1038/nm.2753
doi: 10.1038/nm.2753
pubmed: 22635005
pmcid: 3645291
Razzo BM (2020) Tumor-derived exosomes promote carcinogenesis of murine oral squamous cell carcinoma. Carcinogenesis 41:625–633. https://doi.org/10.1093/carcin/bgz124
doi: 10.1093/carcin/bgz124
pubmed: 31245809
Whiteside TL, Diergaarde B, Hong CS (2021) Tumor-derived exosomes (TEX) and their role in immuno-oncology. Int J Mol Sci 22:6234. https://doi.org/10.3390/ijms22126234
doi: 10.3390/ijms22126234
pubmed: 34207762
pmcid: 8229953
Azambuja JH, Ludwig N, Yerneni SS, Braganhol E, Whiteside TL (2020) Arginase-1+ exosomes from reprogrammed macrophages promote glioblastoma progression. Int J Mol Sci 21:3990. https://doi.org/10.3390/ijms21113990
doi: 10.3390/ijms21113990
pubmed: 32498400
pmcid: 7312363
Whiteside TL (2018) Exosome and mesenchymal stem cell cross-talk in the tumor microenvironment. Semin Immunol 35:69–79. https://doi.org/10.1016/j.smim.2017.12.003
doi: 10.1016/j.smim.2017.12.003
pubmed: 29289420
Barbato S, Solaini G, Fabbri M (2017) MicroRNAs in oncogenesis and tumor suppression. Int Rev Cell Mol Biol 333:229–268. https://doi.org/10.1016/bs.ircmb.2017.05.001
doi: 10.1016/bs.ircmb.2017.05.001
pubmed: 28729026
Zebrowska A, Widlak P, Whiteside T, Pietrowska M (2020) Signaling of tumor-derived sEV impacts melanoma progression. Int J Mol Sci 21:5066. https://doi.org/10.3390/ijms21145066
doi: 10.3390/ijms21145066
pubmed: 32709086
pmcid: 7404104
Clayton A, Al-Taei S, Webber J, Mason MD, Tabi Z (2011) Cancer exosomes express CD39 and CD73, which suppress T cells through adenosine production. J Immunol 187:676–683. https://doi.org/10.4049/jimmunol.1003884
doi: 10.4049/jimmunol.1003884
pubmed: 21677139
Schuler PJ (2014) Human CD4+ CD39+ regulatory T cells produce adenosine upon co-expression of surface CD73 or contact with CD73+ exosomes or CD73+ cells. Clin Exp Immunol 177:531–543. https://doi.org/10.1111/cei.12354
doi: 10.1111/cei.12354
pubmed: 24749746
pmcid: 4226604
Ludwig N (2020) Tumor-derived exosomes promote angiogenesis via adenosine A(2B) receptor signaling. Angiogenesis 23:599–610. https://doi.org/10.1007/s10456-020-09728-8
doi: 10.1007/s10456-020-09728-8
pubmed: 32419057
pmcid: 7529853
Ludwig N, Gillespie DG, Reichert TE, Jackson EK, Whiteside TL (2020) Purine metabolites in tumor-derived Exosomes may facilitate immune escape of head and neck squamous cell carcinoma. Cancers 12:1602. https://doi.org/10.3390/cancers12061602
doi: 10.3390/cancers12061602
pubmed: 32560461
pmcid: 7352909
Ohta A (2006) A2A adenosine receptor protects tumors from antitumor T cells. Proc Natl Acad. Sci 103:13132–13137. https://doi.org/10.1073/pnas.0605251103
doi: 10.1073/pnas.0605251103
pubmed: 16916931
pmcid: 1559765
Jackson EK, Gillespie DG, Cheng D, Mi Z, Menshikova EV (2020) Characterization of the N(6)-etheno-bridge method to assess extracellular metabolism of adenine nucleotides: detection of a possible role for purine nucleoside phosphorylase in adenosine metabolism. Purinergic Signalling 16:187–211. https://doi.org/10.1007/s11302-020-09699-x
doi: 10.1007/s11302-020-09699-x
pubmed: 32367441
pmcid: 7367995
Ludwig N (2019) Isolation and analysis of tumor-derived exosomes. Curr Protoc Immunol 127:e91. https://doi.org/10.1002/cpim.91
doi: 10.1002/cpim.91
pubmed: 31763776
pmcid: 6880756
Hong CS, Funk S, Muller L, Boyiadzis M, Whiteside TL (2016) Isolation of biologically active and morphologically intact exosomes from plasma of patients with cancer. J Extracell Vesicles 5:29289. https://doi.org/10.3402/jev.v5.29289
doi: 10.3402/jev.v5.29289
pubmed: 27018366
Sharma P, Diergaarde B, Ferrone S, Kirkwood JM, Whiteside TL (2020) Melanoma cell-derived exosomes in plasma of melanoma patients suppress functions of immune effector cells. Sci Rep 10:92. https://doi.org/10.1038/s41598-019-56542-4
doi: 10.1038/s41598-019-56542-4
pubmed: 31919420
pmcid: 6952363
Theodoraki MN, Hong CS, Donnenberg VS, Donnenberg AD, Whiteside TL (2021) Evaluation of exosome proteins by on-bead flow cytometry. Cytometry A 99:372–381. https://doi.org/10.1002/cyto.a.24193
doi: 10.1002/cyto.a.24193
pubmed: 33448645
Witwer KW (2021) Updating MISEV: Evolving the minimal requirements for studies of extracellular vesicles. J. Extracell. Vesicles 10:e12182. https://doi.org/10.1002/jev2.12182
doi: 10.1002/jev2.12182
pubmed: 34953156
pmcid: 8710080
Bhattarai S (2015) alpha, beta-Methylene-ADP (AOPCP) derivatives and analogues: development of potent and selective ecto-5’-nucleotidase (CD73) inhibitors. J Med Chem 58:6248–6263. https://doi.org/10.1021/acs.jmedchem.5b00802
doi: 10.1021/acs.jmedchem.5b00802
pubmed: 26147331
Lee SY (2015) Polyoxometalates–potent and selective ecto-nucleotidase inhibitors. Biochem Pharmacol 93:171–181. https://doi.org/10.1016/j.bcp.2014.11.002
doi: 10.1016/j.bcp.2014.11.002
pubmed: 25449596
Hajjar DP (1986) Regulation of neutral cholesteryl esterase in arterial smooth muscle cells: stimulation by agonists of adenylate cyclase and cyclic AMP-dependent protein kinase. Arch Biochem Biophys 247:49–56. https://doi.org/10.1016/0003-9861(86)90531-x
doi: 10.1016/0003-9861(86)90531-x
pubmed: 3010880
Lazarowski ER (2004) Nucleotide release provides a mechanism for airway surface liquid homeostasis. J Biol Chem 279:36855–36864. https://doi.org/10.1074/jbc.M405367200
doi: 10.1074/jbc.M405367200
pubmed: 15210701
Levitt B, Head RJ, Westfall DP (1984) High-pressure liquid chromatographic-fluorometric detection of adenosine and adenine nucleotides: application to endogenous content and electrically induced release of adenyl purines in guinea pig vas deferens. Anal Biochem 137:93–100. https://doi.org/10.1016/0003-2697(84)90352-x
doi: 10.1016/0003-2697(84)90352-x
pubmed: 6731811
Todorov LD (1997) Neuronal release of soluble nucleotidases and their role in neurotransmitter inactivation. Nature 387:76–79. https://doi.org/10.1038/387076a0
doi: 10.1038/387076a0
pubmed: 9139824
Yegutkin GG, Boison D (2022) ATP and adenosine metabolism in cancer: exploitation for therapeutic gain. Pharmacol Rev 74:797–822. https://doi.org/10.1124/pharmrev.121.000528
doi: 10.1124/pharmrev.121.000528
pubmed: 35738682